U curve association of blood pressure and mortality in hemodialysis patients

被引:534
作者
Zager, PG
Nikolic, J
Brown, RH
Campbell, MA
Hunt, WC
Peterson, D
Van Stone, J
Levey, A
Meyer, KB
Klag, MJ
Johnson, HK
Clark, E
Sadler, JH
Teredesai, P
机构
[1] Univ New Mexico, Dept Internal Med & Tumor REgistry, Epidemiol & Canc Control Program, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[2] Dialysis Clin Inc, Nashville, TN USA
[3] Tufts Univ New England Med Ctr, Boston, MA 02111 USA
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
hypertension; cardiovascular/cerebrovascular mortality; dialysis; survival; anti-hypertensive drugs;
D O I
10.1046/j.1523-1755.1998.00005.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Hypertension may play an important role in the pathogenesis of the excess cardiovascular and cerebrovascular (CV) morbidity observed in hemodialysis patients (HD). However, the optimal blood pressure (BP) range for HD patients has not been defined. We postulated that there is a "U" curve relationship between BP and CV mortality. To explore this hypothesis we studied 5,433 HD patients in Dialysis Clinic Inc., a large not-for-profit chain, over a five year period. Methods. Cox regression, with fixed and time-varying covariates. was used to assess the effect of systolic blood pressure (SBP) and diastolic blood pressure (DBP), pre- and post-dialysis, on CV mortality, while adjusting for age, gender, ethnicity, primary cause of end-stage renal disease, Kt/V, serum albumin, and antihypertensive medications. Results. The overall impact of BP on CV mortality was modest. Pre-dialysis, neither systolic nor diastolic hypertension were associated with an increase in CV mortality. Post-dialysis, SEP greater than or equal to 180 mm Hg (RR = 1.96, P < 0.015) and DBP greater than or equal to 90 mm Hg (RR = 1.73, P < 0.05) were associated with increased CV mortality. Low SEP (SBP < 110 mm Hg) was associated with increased CV mortality, pre- and post-dialysis. Conclusions. The results suggest the presence of a "U" curve relationship between SEP post-dialysis and CV mortality in HD patients.
引用
收藏
页码:561 / 569
页数:9
相关论文
共 49 条
[11]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[12]   SYMPATHETIC OVERACTIVITY IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
CONVERSE, RL ;
JACOBSEN, TN ;
TOTO, RD ;
JOST, CMT ;
COSENTINO, F ;
FOUADTARAZI, F ;
VICTOR, RG .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1912-1918
[13]   THE RELATION BETWEEN DEGREE OF BLOOD-PRESSURE REDUCTION AND MORTALITY AMONG HYPERTENSIVES IN THE HYPERTENSION DETECTION AND FOLLOW-UP PROGRAM [J].
COOPER, SP ;
HARDY, RJ ;
LABARTHE, DR ;
HAWKINS, CM ;
SMITH, EO ;
BLAUFOX, MD ;
COOPER, CJ ;
ENTWISLE, G ;
MAXWELL, MH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 127 (02) :387-403
[14]   CORONARY FLOW RESERVE AND THE J-CURVE RELATION BETWEEN DIASTOLIC BLOOD-PRESSURE AND MYOCARDIAL-INFARCTION [J].
CRUICKSHANK, JM .
BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6658) :1227-1230
[15]  
CRUICKSHANK JM, 1987, LANCET, V1, P581
[16]  
DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205
[17]  
*DEP HLTH HUM SERV, 1996, 1995 COR IND PROJ IN
[18]  
Duranti E, 1996, KIDNEY INT, pS173
[19]   THE J-CURVE PHENOMENON AND THE TREATMENT OF HYPERTENSION - IS THERE A POINT BEYOND WHICH PRESSURE REDUCTION IS DANGEROUS [J].
FARNETT, L ;
MULROW, CD ;
LINN, WD ;
LUCEY, CR ;
TULEY, MR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04) :489-495
[20]   SIMULTANEOUS ANALYSIS OF MORBIDITY AND MORTALITY FACTORS IN CHRONIC-HEMODIALYSIS PATIENTS [J].
FERNANDEZ, JM ;
CARBONELL, ME ;
MAZZUCHI, N ;
PETRUCCELLI, D .
KIDNEY INTERNATIONAL, 1992, 41 (04) :1029-1034